Lunit participates in Singapore's AI diagnostic solution project

The company plans to take part in NHG's chest X-ray reading workflow improvement project

Lunit participates in Singapore's AI diagnostic solution project
Jeong Min Nam 1
2024-08-14 14:54:41 peux@hankyung.com
Bio & Pharma

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that it solely participates in a chest X-ray reading workflow improvement project led by Singapore's National Healthcare Group (NHG).

According to Lunit, Singapore's public healthcare services are divided among three healthcare institutions, with NHG responsible for the central and northern regions of Singapore.

The purpose of this project is to verify the effectiveness of using AI in improving the chest X-ray reading process and the efficiency of medical resource allocation at NHG-affiliated medical institutions.

Lunit plans to install its chest X-ray AI image analysis solution Lunit Insight CXR at primary care institutions under NHG to enhance the efficiency of the reading system.

NHG plans to conduct the project until August next year and, if the value of AI utilization is proven, will propose to the Singaporean government to improve the image reading protocols for public hospitals.

Write to Jeong Min Nam at peux@hankyung.com
#Lunit #National Healthcare Group #NHG #Lunit Insight CXR

Lunit to supply AI cancer diagnostics to Qatar

Lunit to supply AI cancer diagnostics to Qatar

Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Insight MMG for Qatar's Primary Health Care Corp. (PHCC)-led National Breast Cancer Screening Project.Qatar's PHCC recommends women aged between 45 a

Lunit eyes developing markets with AI cancer diagnostics

Lunit eyes developing markets with AI cancer diagnostics

Lunit CEO Brandon Suh Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagnostic technology and infrastructure, said its chief on Monday. “Our goal is to use AI to promote early diagnosis of bre

Lunit buys breast cancer detection AI firm Volpara Health

Lunit buys breast cancer detection AI firm Volpara Health

 Teri Thomas, chief executive of Volpara Health (left), Brandon Suh, CEO of Lunit Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection, for 264.7 bi

Lunit, Radiobotics team up to enter EMEA markets

Lunit, Radiobotics team up to enter EMEA markets

South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS to enter the Europe, Middle East, and Africa (EMEA) markets. Under the agreement, the company will distribute Radiobotics' fracture and trau

Lunit gets court approval for Volpara acquisition in New Zealand

Lunit gets court approval for Volpara acquisition in New Zealand

South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to acquire New Zealand-based AI breast cancer diagnostics solutions company Volpara Health Technologies.According to Lunit, the acquisition approval p
(* comment hide *}